CDK10 Polyklonaler Antikörper
CDK10 Polyklonal Antikörper für WB, IF/ICC, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human, Maus
Anwendung
WB, IF/ICC, Indirect ELISA
Konjugation
Unkonjugiert
Kat-Nr. : 30061-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
30061-1-PBS bindet in WB, IF/ICC, Indirect ELISA CDK10 und zeigt Reaktivität mit human, Maus
| Getestete Reaktivität | human, Maus |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Polyklonal |
| Typ | Antikörper |
| Immunogen | CDK10 fusion protein Ag30365 |
| Vollständiger Name | cyclin-dependent kinase 10 |
| Berechnetes Molekulargewicht | 283 aa, 32 kDa |
| Beobachtetes Molekulargewicht | 38 kDa |
| GenBank-Zugangsnummer | BC017342 |
| Gene symbol | CDK10 |
| Gene ID (NCBI) | 8558 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Antigen-Affinitätsreinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
Cyclin-dependent kinase 10 (CDK10) is a Cdc2-related kinase that was discovered based on its homology to the Cdc2 PSTA1RE amino acid domain (PMID: 8208557). CDK10 plays a pivotal role in the regulation of fundamental cellular processes, including cell proliferation, transcription regulation, and cell cycle regulation. It partners with cyclin M to phosphorylate substrates such as ETS2 and PKN2 in order to modulate cellular growth. Initial reports have indicated that CDK10 may act as a tumor suppressor in breast cancer (PMID: 26392360). Additional studies have demonstrated tumor suppressive and oncogenic roles for CDK10 in malignancies such as hepatobiliary cancers, gastric cancer, glioma, nasopharyngeal carcinoma, and colorectal cancer(PMID: 22326270, PMID: 29512714, PMID: 23740091, PMID: 29845196)



